OrbiMed Genesis GP LLC
Insider CIK 1808744 · SRRA Director, 10% owner · SCPH 10% owner · ALPN Director, 10% owner · DBTX Director, 10% owner · QTTB Director, 10% owner · LOGC Director, 10% owner · KROS Director · ELVN Director, 10% owner · PRLD Director, 10% owner · STTK Director · PMVP Director, 10% owner · EWTX Director, 10% owner · ACET Director, 10% owner · CMPX Director, 10% owner · THRX Director, 10% owner · MBX Director, 10% owner · KNTE Director, 10% owner · GLTO Director, 10% owner · ADRX Director, 10% owner · IRON Director, 10% owner · JANX Director · TERN Director, 10% owner · IKNA Director · ETRA Director, 10% owner · BRVE Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 588,235 | $17.00 | $10.00M | 588,235 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 61,516 | $17.00 | $1.05M | 9,292,025 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 10,690,530 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 12,691,492 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 13,461,093 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 9,230,509 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 8,974,061 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 8,460,994 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 7,127,019 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 300,249 | $17.00 | $5.10M | 14,325,529 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 14,025,280 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 588,235 | $17.00 | $10.00M | 588,235 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 61,516 | $17.00 | $1.05M | 9,292,025 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 256,448 | — | — | 9,230,509 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 513,067 | — | — | 8,974,061 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 1,333,975 | — | — | 8,460,994 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 7,127,019 | — | — | 7,127,019 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 300,249 | $17.00 | $5.10M | 14,325,529 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 564,187 | — | — | 14,025,280 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 769,601 | — | — | 13,461,093 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 2,000,962 | — | — | 12,691,492 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 10,690,530 | — | — | 10,690,530 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 3,090,244 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 4,793,558 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 2,002,310 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | — | 758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | — | 4,793,558 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | — | 3,090,244 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | — | 2,002,310 | SEC↗ |
| BRVE Braveheart Bio, Inc. | C Conversion deriv | 2026-08-07 | 2026-08-11 | 40,000,000 | — | $0 | 0 | SEC↗ |
| BRVE Braveheart Bio, Inc. | P Buy | 2026-08-07 | 2026-08-11 | 273,333 | $18.00 | $4.92M | 273,333 | SEC↗ |
| BRVE Braveheart Bio, Inc. | C Conversion | 2026-08-07 | 2026-08-11 | 9,132,420 | — | $0 | 10,235,159 | SEC↗ |
| BRVE Braveheart Bio, Inc. | P Buy | 2026-08-07 | 2026-08-11 | 1,666,667 | $18.00 | $30.00M | 11,901,826 | SEC↗ |
| BRVE Braveheart Bio, Inc. | C Conversion deriv | 2026-08-07 | 2026-08-11 | 40,000,000 | — | $0 | 0 | SEC↗ |
| BRVE Braveheart Bio, Inc. | P Buy | 2026-08-07 | 2026-08-11 | 273,333 | $18.00 | $4.92M | 273,333 | SEC↗ |
| BRVE Braveheart Bio, Inc. | P Buy | 2026-08-07 | 2026-08-11 | 1,666,667 | $18.00 | $30.00M | 11,901,826 | SEC↗ |
| BRVE Braveheart Bio, Inc. | C Conversion | 2026-08-07 | 2026-08-11 | 9,132,420 | — | — | 10,235,159 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 1,477 | $45.00 | $66.5K | 219,405 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 787,024 | $45.38 | $35.72M | 6,601,878 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 46,776 | $45.00 | $2.10M | 6,555,102 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 24,846 | $45.38 | $1.13M | 220,882 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 272,322 | $45.02 | $12.26M | 7,388,902 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 9,086 | $45.02 | $409.1K | 245,728 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy deriv | 2026-06-11 | 2026-06-15 | 208,333 | — | $0 | 5,303,908 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy deriv | 2026-06-11 | 2026-06-15 | 1,041,667 | — | $0 | 26,519,541 | SEC↗ |
| STTK Shattuck Labs, Inc. | C Conversion deriv | 2026-06-08 | 2026-06-09 | 15,366,490 | — | $0 | 25,477,874 | SEC↗ |
| STTK Shattuck Labs, Inc. | C Conversion deriv | 2026-06-08 | 2026-06-09 | 3,073,298 | — | $0 | 5,095,575 | SEC↗ |
| STTK Shattuck Labs, Inc. | C Conversion deriv | 2026-06-08 | 2026-06-09 | 15,366,490 | — | $0 | 0 | SEC↗ |
| STTK Shattuck Labs, Inc. | C Conversion deriv | 2026-06-08 | 2026-06-09 | 3,073,298 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | P Buy | 2026-05-28 | 2026-06-01 | 1,250,000 | $8.00 | $10.00M | 3,502,987 | SEC↗ |
| QTTB Q32 Bio Inc. | P Buy | 2026-05-28 | 2026-06-01 | 625,000 | $8.00 | $5.00M | 625,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2026-04-21 | 2026-04-23 | 1,126,126 | $4.44 | $5.00M | 1,126,126 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2026-04-21 | 2026-04-23 | 1,689,189 | $4.44 | $7.50M | 11,808,945 | SEC↗ |
| IMA ImageneBio, Inc. | P Buy deriv | 2026-04-14 | 2026-04-16 | 336,603 | — | $0 | 336,603 | SEC↗ |
| IMA ImageneBio, Inc. | P Buy deriv | 2026-04-14 | 2026-04-16 | 384,689 | — | $0 | 384,689 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 40,416 | $6.52 | $263.5K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 32,523 | $6.29 | $204.6K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 2,400 | $6.38 | $15.3K | 32,523 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 29,319 | $6.53 | $191.5K | 34,923 | SEC↗ |
| KROS Keros Therapeutics, Inc. | D To issuer | 2025-11-21 | 2025-12-18 | 74,465 | $17.75 | $1.32M | 45,057 | SEC↗ |
| KROS Keros Therapeutics, Inc. | D To issuer | 2025-11-21 | 2025-12-18 | 140,057 | $17.75 | $2.49M | 759,155 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 3,500,000 | $1.00 | $3.50M | 4,490,254 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 1,500,000 | $1.00 | $1.50M | 9,026,359 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy deriv | 2025-08-25 | 2025-09-02 | 15,366,490 | — | $0 | 15,366,490 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy deriv | 2025-08-25 | 2025-09-02 | 3,073,298 | — | $0 | 3,073,298 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy deriv | 2025-08-25 | 2025-09-02 | 10,111,384 | — | $0 | 10,111,384 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy deriv | 2025-08-25 | 2025-09-02 | 2,022,277 | — | $0 | 2,022,277 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2025-08-25 | 2025-09-02 | 1,051,021 | $0.87 | $914.4K | 1,051,021 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2025-08-25 | 2025-09-02 | 5,255,106 | $0.87 | $4.57M | 5,255,106 | SEC↗ |
| IKNA ImageneBio, Inc. | A Award | 2025-07-25 | 2025-07-30 | 83,611 | $2.49 | $208.2K | 287,885 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | S Sale | 2025-04-09 | 2025-04-11 | 3,571,428 | $1.59 | $5.68M | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2025-04-03 | 2025-04-04 | 372,578 | $20.13 | $7.50M | 14,809,075 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2025-04-03 | 2025-04-04 | 124,193 | $20.13 | $2.50M | 443,792 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 1,956 | $54.11 | $105.8K | 482,308 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 3,026 | $54.11 | $163.7K | 746,171 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 756 | $54.11 | $40.9K | 186,541 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 1,320 | $54.00 | $71.3K | 187,297 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 5,279 | $54.00 | $285.1K | 749,197 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 3,412 | $54.00 | $184.2K | 484,264 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 364 | $54.01 | $19.7K | 188,617 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 1,457 | $54.01 | $78.7K | 754,476 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 941 | $54.01 | $50.8K | 487,676 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 5,228 | $54.02 | $282.4K | 188,981 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 20,911 | $54.02 | $1.13M | 755,933 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 13,517 | $54.02 | $730.2K | 488,617 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 10,733 | $54.44 | $584.3K | 194,209 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 603 | $55.05 | $33.2K | 529,884 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 933 | $55.05 | $51.4K | 819,774 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 233 | $55.05 | $12.8K | 204,942 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 42,930 | $54.44 | $2.34M | 776,844 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 27,750 | $54.44 | $1.51M | 502,134 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 9,222 | $54.01 | $498.1K | 530,487 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 14,267 | $54.01 | $770.6K | 820,707 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 3,567 | $54.01 | $192.7K | 205,175 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 68,766 | $54.29 | $3.73M | 539,845 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 106,384 | $54.29 | $5.78M | 835,185 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 26,596 | $54.29 | $1.44M | 208,795 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 136 | $55.01 | $7.5K | 539,709 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 211 | $55.01 | $11.6K | 834,974 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 53 | $55.01 | $2.9K | 208,742 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-18 | 2025-02-19 | 49,070 | $10.84 | $531.9K | 3,255,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-18 | 2025-02-19 | 94,100 | $10.84 | $1.02M | 747,887 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-14 | 2025-02-19 | 29,540 | $9.85 | $291.0K | 3,205,930 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-14 | 2025-02-19 | 17,962 | $9.90 | $177.8K | 3,176,390 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 4,854,368 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 19,587,284 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,372,634 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 250,000 | $16.00 | $4.00M | 653,787 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 403,787 | — | $0 | 403,787 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,158,428 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 2,658,428 | — | $0 | 2,658,428 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2024-08-13 | 2024-08-15 | 478,342 | $4.00 | $1.91M | 5,806,670 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2024-08-13 | 2024-08-15 | 21,658 | $4.00 | $86.6K | 252,858 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 220,600 | $44.01 | $9.71M | 899,212 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 29,400 | $44.01 | $1.29M | 119,522 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 556 | $10.00 | $5.6K | 1,967,924 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 4,009 | $10.00 | $40.1K | 4,839,412 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 623 | $10.00 | $6.2K | 755,635 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 39,433 | $10.00 | $394.3K | 4,843,421 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 5,401 | $10.00 | $54.0K | 1,968,480 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 6,142 | $10.00 | $61.4K | 756,258 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 43,944 | $36.00 | $1.58M | 941,569 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 10,986 | $36.00 | $395.5K | 235,391 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 28,404 | $36.00 | $1.02M | 608,611 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | U Tender | 2024-05-18 | 2024-05-20 | 264,315 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | U Tender | 2024-05-18 | 2024-05-20 | 2,416,181 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-16 | 2024-05-20 | 1,000,000 | $22.14 | $22.14M | 7,663,349 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-16 | 2024-05-20 | 33,300 | $22.14 | $737.3K | 254,814 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 84,599 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 450,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,338 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,339 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 4,738,453 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 17,063,000 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 650,600 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,841,100 | $2.40 | $4.42M | 7,526,359 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,041,700 | $2.40 | $2.50M | 1,255,985 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 242,200 | $2.40 | $581.3K | 990,254 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2024-01-23 | 2024-01-25 | 454,545 | $11.00 | $5.00M | 14,436,497 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | X Exercise deriv | 2024-01-11 | 2024-01-16 | 145,251 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | X Exercise | 2024-01-11 | 2024-01-16 | 145,251 | $12.74 | $1.85M | 2,416,181 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-28 | 2023-12-29 | 3,128 | $19.82 | $62.0K | 403,481 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-28 | 2023-12-29 | 1,195,683 | $18.32 | $21.90M | 2,270,930 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-28 | 2023-12-29 | 139,166 | $18.32 | $2.55M | 264,315 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-28 | 2023-12-29 | 26,872 | $19.82 | $532.6K | 3,466,613 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-27 | 2023-12-29 | 162,576 | $19.96 | $3.25M | 3,493,485 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-27 | 2023-12-29 | 18,922 | $19.96 | $377.7K | 406,609 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-20 | 1,724 | — | $0 | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-18 | 2023-12-20 | 1,724 | $59.24 | $102.1K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2023-12-18 | 2023-12-20 | 1,724 | $38.00 | $65.5K | 1,724 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 100 | $57.73 | $5.8K | 1,126,125 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 100 | $57.73 | $5.8K | 727,807 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 228,500 | $56.75 | $12.97M | 897,625 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 57,100 | $56.75 | $3.24M | 224,405 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 147,600 | $56.75 | $8.38M | 580,207 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 36,400 | $58.56 | $2.13M | 727,907 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 14,100 | $58.56 | $825.7K | 281,505 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 56,200 | $58.56 | $3.29M | 1,126,225 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 3,600 | $60.16 | $216.6K | 295,605 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 9,300 | $60.16 | $559.5K | 764,307 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 14,400 | $60.16 | $866.3K | 1,182,425 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2023-11-22 | 2023-11-24 | 87,786 | $2.23 | $195.8K | 0 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 248,819 | $0.75 | $186.6K | 631,048 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 38,327 | $0.75 | $28.7K | 97,204 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 535,534 | $0.75 | $401.7K | 1,510,375 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-08-04 | 2023-09-14 | 353,192 | — | $0 | 353,192 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-08-04 | 2023-09-21 | 353,192 | — | $0 | 353,192 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award | 2023-08-04 | 2023-09-14 | 153,121 | — | $0 | 2,251,218 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award | 2023-08-04 | 2023-09-21 | 153,121 | — | $0 | 5,582,144 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 153,078 | $3.00 | $459.2K | 2,105,909 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 29,700 | $3.00 | $89.1K | 879,867 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 26,622 | $3.00 | $79.9K | 135,531 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 4,700 | $2.92 | $13.7K | 909,567 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 7,800 | $2.92 | $22.8K | 162,153 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 26,700 | $2.92 | $78.0K | 2,258,987 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 151,450 | $3.05 | $461.9K | 650,600 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 328,482 | $3.05 | $1.00M | 17,063,000 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 52,800 | $2.40 | $126.7K | 914,267 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 132,100 | $2.40 | $317.0K | 2,285,687 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 9,800 | $2.40 | $23.5K | 169,953 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 125,000 | $2.09 | $261.2K | 1,027,885 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 250,000 | $2.09 | $522.5K | 646,657 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 442,000 | $2.09 | $923.8K | 5,685,259 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 58,000 | $2.09 | $121.2K | 748,054 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-05-17 | 2023-05-19 | 2,125 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-05-17 | 2023-05-19 | 2,125 | $4.28 | $9.1K | 8,663,349 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,512 | $2.82 | $1.38M | 1,368,339 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,511 | $2.82 | $1.38M | 1,368,338 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 312,991 | $2.75 | $860.7K | 4,738,453 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 220,610 | $2.67 | $589.0K | 4,425,462 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,544 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 467,068 | $2.62 | $1.22M | 4,204,852 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,545 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 228,754 | $2.55 | $583.3K | 3,737,784 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,997 | $2.55 | $155.5K | 610,997 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,998 | $2.55 | $155.5K | 610,998 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 660 | $1.97 | $1.3K | 179,753 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 8,878 | $1.97 | $17.5K | 2,417,787 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 3,551 | $1.97 | $7.0K | 967,067 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 28,110 | $1.86 | $52.3K | 2,426,665 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 11,245 | $1.86 | $20.9K | 970,618 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 2,091 | $1.86 | $3.9K | 180,413 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 703 | $1.82 | $1.3K | 182,504 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 3,784 | $1.82 | $6.9K | 981,863 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 9,459 | $1.82 | $17.2K | 2,454,775 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 641 | $1.81 | $1.2K | 985,647 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 119 | $1.81 | $215 | 183,207 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 1,603 | $1.81 | $2.9K | 2,464,234 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 3,784 | $1.82 | $6.9K | 986,288 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 703 | $1.82 | $1.3K | 183,326 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 9,459 | $1.82 | $17.2K | 2,465,837 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 34,745 | $1.79 | $62.2K | 2,500,582 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 13,899 | $1.79 | $24.9K | 1,000,187 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 2,584 | $1.79 | $4.6K | 185,910 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 487 | $2.00 | $974 | 186,613 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 2,620 | $2.00 | $5.2K | 1,003,971 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 6,558 | $2.00 | $13.1K | 2,510,041 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 4,687 | $2.18 | $10.2K | 187,100 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 63,058 | $2.18 | $137.5K | 2,516,599 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 25,220 | $2.18 | $55.0K | 1,006,591 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 7,611,458 | — | $0 | 8,661,225 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 288,114 | — | $0 | 288,114 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 37,049 | $23.00 | $852.1K | 773,607 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 57,318 | $23.00 | $1.32M | 1,196,825 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 14,329 | $23.00 | $329.6K | 299,205 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 284,876 | — | $0 | 284,876 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 153,936 | — | $0 | 736,558 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 582,622 | — | $0 | 582,622 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 1,139,507 | — | $0 | 1,139,507 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-12-23 | 2022-12-28 | 137,931 | $7.25 | $1000.0K | 4,882,854 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2022-11-25 | 2022-11-29 | 762,380 | $5.25 | $4.00M | 5,328,328 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-11-08 | 2022-11-10 | 402,000 | $3.21 | $1.29M | 15,219,994 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-11-07 | 2022-11-09 | 192,000 | $5.21 | $1.00M | 16,734,518 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2022-09-16 | 2022-09-16 | 484,496 | $10.32 | $5.00M | 13,981,952 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 38,450 | — | $0 | 38,450 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 207,500 | — | $0 | 207,500 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 64,050 | — | $0 | 64,050 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 457,400 | $2.42 | $1.11M | 1,973,881 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 762,400 | $2.42 | $1.85M | 762,400 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 2,470,200 | $2.42 | $5.98M | 4,744,923 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,136,250 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 170,437 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 170,437 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 226,704 | $55.00 | $12.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 226,704 | $55.00 | $12.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 1,511,362 | $55.00 | $83.12M | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-24 | 2022-06-24 | 96,035 | $5.37 | $515.7K | 2,098,097 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-24 | 2022-06-24 | 65,965 | $4.37 | $288.3K | 2,002,062 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-23 | 2022-06-24 | 23,419 | $3.71 | $86.9K | 1,936,097 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-22 | 2022-06-24 | 66,806 | $3.55 | $237.2K | 1,912,678 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-05-26 | 2022-05-31 | 26,253 | $15.93 | $418.2K | 87,786 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2022-05-18 | 2022-05-20 | 138,000 | $7.21 | $995.0K | 13,497,456 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-13 | 2022-05-13 | 30,722 | $2.49 | $76.5K | 14,817,994 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-12 | 2022-05-13 | 97,094 | $2.35 | $228.2K | 14,787,272 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-11 | 2022-05-13 | 64,700 | $1.79 | $115.8K | 14,690,178 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-10 | 2022-05-10 | 24,447 | $1.60 | $39.1K | 14,625,478 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-09 | 2022-05-10 | 90,712 | $1.56 | $141.5K | 14,601,031 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-06 | 2022-05-10 | 10,200 | $1.63 | $16.6K | 14,510,319 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-31 | 2022-03-31 | 34,500 | $21.17 | $730.4K | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-30 | 2022-03-31 | 75,000 | $22.39 | $1.68M | 34,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-29 | 2022-03-31 | 365,000 | $21.52 | $7.85M | 109,500 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-15 | 2022-02-15 | 9,000 | $9.96 | $89.6K | 3,509,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-14 | 2022-02-15 | 10,000 | $9.89 | $98.9K | 3,500,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-14 | 2022-02-15 | 20,700 | $9.98 | $206.6K | 3,490,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-11 | 2022-02-15 | 156,000 | $10.22 | $1.59M | 3,469,330 | SEC↗ |